COVID-19 EditorialLong-Term Care Facilities and the Coronavirus Epidemic: Practical Guidelines for a Population at Highest Risk
Cited by (0)
The authors declare no conflicts of interest. D.D. has grant support from VA HSR&D and the National Institutes of Aging; R.J. is the Principal Investigator on research grants from the Pfizer, Merck, and Accelerate; she has also participated in advisory boards for Pfizer and Roche; K.L. has grant support from VA HSR&D and has received research funding or acted as a scientific advisor for Merck, Ocean Spray, Pfizer, Allergan, Nabriva, and Paratek. Lastly, S.G. has grant support from NIH and has received research funding from Sanofi, Sequirus, Longeveron, Pfizer, Merck, and Janssen.
Published by Elsevier Inc. on behalf of AMDA - The Society for Post-Acute and Long-Term Care Medicine.